BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 38191289)

  • 21. Outcome analysis of pediatric hemophagocytic lymphohistiocytosis.
    Chen TY; Hsu MH; Kuo HC; Sheen JM; Cheng MC; Lin YJ
    J Formos Med Assoc; 2021 Jan; 120(1 Pt 1):172-179. PubMed ID: 32307323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with severe cardiac complications.
    Kawamura Y; Miura H; Matsumoto Y; Uchida H; Kudo K; Hata T; Ito Y; Kimura H; Yoshikawa T
    BMC Pediatr; 2016 Oct; 16(1):172. PubMed ID: 27793118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignancy-induced hemophagocytic lymphohistiocytosis in a case of signet ring cell carcinoma of the stomach.
    Ramkumar S
    Indian J Pathol Microbiol; 2021 Jun; 64(Supplement):S85-S88. PubMed ID: 34135144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An unforeseen reality: Hemophagocytic lymphohistiocytosis following alemtuzumab treatment for a multiple sclerosis.
    Ošep AB; Brecl E; Škerget M; Savšek L
    Clin Neurol Neurosurg; 2023 May; 228():107675. PubMed ID: 36965418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial Hemophagocytic Lymphohistiocytosis secondary to UNC13D mutation: a report of two cases.
    Sadeghi P; Esslami GG; Rokni-Zadeh H; Changi-Ashtiani M; Mohsenipour R
    BMC Pediatr; 2022 Nov; 22(1):667. PubMed ID: 36401200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLH as an additional warning sign of inborn errors of immunity beyond familial-HLH in children: a systematic review.
    Ricci S; Sarli WM; Lodi L; Canessa C; Lippi F; Dini D; Ferrari M; Pisano L; Sieni E; Indolfi G; Resti M; Azzari C
    Front Immunol; 2024; 15():1282804. PubMed ID: 38415256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lamotrigine-Induced Hemophagocytic Lymphohistiocytosis with DRESS.
    Wang H; Peng J; Zeng W; Pan X
    Clin Lab; 2024 Feb; 70(2):. PubMed ID: 38345991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of hemophagocytic lymphohistiocytosis with alemtuzumab in systemic lupus erythematosus.
    Keith MP; Pitchford C; Bernstein WB
    J Clin Rheumatol; 2012 Apr; 18(3):134-7. PubMed ID: 22426581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemophagocytic Lymphohistiocytosis Occurring in Inflammatory Bowel Disease: Systematic Review.
    Coburn ES; Siegel CA; Winter M; Shah ED
    Dig Dis Sci; 2021 Mar; 66(3):843-854. PubMed ID: 32300936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effective Treatment of a Melanoma Patient with Hemophagocytic Lymphohistiocytosis after Nivolumab and Ipilimumab Combined Immunotherapy.
    Pacholczak-Madej R; Grela-Wojewoda A; Lompart J; Żuchowska-Vogelgesang B; Ziobro M
    Prague Med Rep; 2022; 123(1):35-42. PubMed ID: 35248163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: A systematic scoping review.
    Hayden A; Park S; Giustini D; Lee AY; Chen LY
    Blood Rev; 2016 Nov; 30(6):411-420. PubMed ID: 27238576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Auto-immune hemolytic anemia and hemophagocytic lymphohistiocytosis as immune-related adverse event in patients with metastatic melanoma and concurrent chronic lymphocytic leukemia: a case series and literature review.
    Dirven I; Vander Mijnsbrugge AS; Mignon S; Tijtgat J; Kint N; Neyns B
    Melanoma Res; 2023 Aug; 33(4):338-344. PubMed ID: 37114670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PD-1 blockader-associated atypical hemophagocytic lymphohistiocytosis: A cautionary case report.
    He L; Zhuang Y; Zhang D; Tang Z
    Transfus Apher Sci; 2023 Apr; 62(2):103603. PubMed ID: 36470726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemophagocytic Lymphohistiocytosis Secondary to PD-1 and IDO Inhibition in a Patient with Refractory Glioblastoma.
    Thummalapalli R; Heumann T; Stein J; Khan S; Priemer DS; Duffield AS; Laterra J; Couzi R; Lim M; Holdhoff M
    Case Rep Oncol; 2020; 13(2):508-514. PubMed ID: 32518546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secondary hemophagocytic lymphohistiocytosis due to nivolumab/ipilimumab in a renal cell cancer patient-A case report.
    Masood A; Wahab A; Clifford T; Weaver EJ; Ehsan H; El Ayass W
    Clin Case Rep; 2021 Dec; 9(12):e05184. PubMed ID: 34917381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemophagocytic lymphohistiocytosis associated with the use of lamotrigine.
    Kim T; Kulick CG; Kortepeter CM; Brinker A; Waldron P
    Neurology; 2019 May; 92(21):e2401-e2405. PubMed ID: 30996059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemophagocytic Lymphohistiocytosis in Cutaneous T-Cell Lymphoma.
    Lee DE; Martinez-Escala ME; Serrano LM; Zhou XA; Kaplan JB; Pro B; Choi J; Guitart J
    JAMA Dermatol; 2018 Jul; 154(7):828-831. PubMed ID: 29874360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis.
    Parikh SA; Kapoor P; Letendre L; Kumar S; Wolanskyj AP
    Mayo Clin Proc; 2014 Apr; 89(4):484-92. PubMed ID: 24581757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of pediatric visceral leishmaniasis-related hemophagocytic lymphohistiocytosis diagnosed by mNGS.
    Guo F; Kang L; Xu M
    Int J Infect Dis; 2020 Aug; 97():27-29. PubMed ID: 32425641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics and predictors of post-transplant-associated hemophagocytic lymphohistiocytosis in adults.
    Hattori N; Sato M; Uesugi Y; Nakata A; Sasaki Y; Shimada S; Watanuki M; Fujiwara S; Kawaguchi Y; Arai N; Uto Y; Matsui T; Yanagisawa K; Tahara S; Koeffler HP; Iezumi K; Nakamaki T
    Int J Hematol; 2021 May; 113(5):693-702. PubMed ID: 33385294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.